# TREATMENT OF VAGINAL DRYNESS IN SJÖGREN'S DISEASE WITH CO2-LASER VERSUS TOPICAL PROMESTRIENE

> **NCT07153276** · PHASE4 · RECRUITING · sponsor: **University of Sao Paulo General Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Sjogren Syndrome
- Sjogren Disease
- Primary Sjogren Syndrome

## Interventions

- **DEVICE:** Fractional CO2 laser (vaginal)
- **DRUG:** Promestriene Vaginal

## Key facts

- **NCT ID:** NCT07153276
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-27
- **Primary completion:** 2029-09-27
- **Final completion:** 2030-01-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-03-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07153276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07153276, "TREATMENT OF VAGINAL DRYNESS IN SJÖGREN'S DISEASE WITH CO2-LASER VERSUS TOPICAL PROMESTRIENE". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07153276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*